Qiagen Nv stock was originally listed at a price of $5.79 in Dec 31, 1997. QIAGEN's stock was trading at $41.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). 0 analysts 0%. View which stocks are hot on social media with MarketBeat's trending stocks report. Qiagen (QGEN) delivered earnings and revenue surprises of 5.46% and 7.62%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock? High institutional ownership can be a signal of strong market trust in this company. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. ; bioinformatics solutions; and human ID/forensics sample collection consumables and human ID/forensics sample collection consumables. Earnings vs Savings Rate: QGEN's forecast earnings growth (15.2% per year) is above the savings rate (2%). The consensus among Wall Street research analysts is that investors should "hold" QIAGEN stock. Receive a free world-class investing education from MarketBeat. Avg Forecast. With a 5-year investment, the revenue is expected to be around +41.38%. Max Forecast. QGEN Stock Analysis Overview . MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The Qiagen N.V. stock price gained 0.76% on the last trading day (Tuesday, 12th Jan 2021), rising from $52.56 to $52.96., and has now gained 3 days in a row. What is QGEN's forecast return on equity (ROE) for 2021-2024? MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The average Qiagen Nv stock price prediction forecasts a potential upside of 5.22% from the current QGEN share price of $54.33. The company provided EPS guidance of $2.42-2.46 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.47. The consensus among 10 Wall Street analysts covering (NYSE: QGEN) stock is to Buy QGEN stock. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Top-ranked 20 MM forecast alternatives out of the MM forecast population of 3001 have upside fom average prospects larger than other medical diagnostic alternatives.. Earnings for QIAGEN are expected to grow by 15.02% in the coming year, from $2.13 to $2.45 per share. Qiagen previously expected 2020 adjusted EPS to come at $2.07-$2.09. Forecasted annual earnings growth. What is QGEN's Earnings Per Share (EPS) forecast for 2021-2023? Area, Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', Buy Kinder Morgan, Inc While It Still Yields 6.75%. According to 6 Wall Street analysts that have issued a 1 year QGEN price target, the average QGEN price target is $57.17, with the highest QGEN stock price forecast at $62.00 and the lowest QGEN stock price forecast at $50.00. What is QGEN's forecast return on assets (ROA) for 2021-2024? 18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for QIAGEN in the last year. $57.17 +7.19%. 15.2%. Buy. QIAGEN has received 218 “outperform” votes. QIAGEN N.V. earnings per share revisions and analysts forecast | Nyse: QGEN | Nyse Wall Street analysts have given QIAGEN a "Hold" rating, but there may be better short-term opportunities in the market. QIAGEN's mailing address is HULSTERWEG 82, VENLO P7, 5912. The reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.56 by $0.02. Get short term trading ideas from the MarketBeat Idea Engine. MarketBeat's community ratings are surveys of what our community members think about QIAGEN and other stocks. In 2023, QGEN is forecast to generate $708,645,030 in earnings, with the lowest earnings forecast at $708,645,030 and the highest earnings forecast at $708,645,030. The all-time high QIAGEN stock closing price was 59.58 on July 17, 2000. The company had revenue of $483.76 million for the quarter, compared to analysts' expectations of $449.50 million. QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. Earnings and Revenue Growth Forecasts . Global Bacterial and Plasmid Vectors Market, Split by Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion Companies Mentioned Sigma-Aldrich Inc. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. QIAGEN does not currently pay a dividend. Their forecasts range from $36.00 to $66.00. QIAGEN has a PEG Ratio of 1.29. Qiagen NV Stock Forecast is based on your current time horizon. © American Consumer News, LLC dba MarketBeat® 2010-2021. Fundamental company data provided by Morningstar and Zacks Investment Research. However, solely looking at the historical price movement is usually misleading. Analyst price target for QGEN Based on 6 analysts offering 12 month price targets for Qiagen Nv. In 2023, QGEN is forecast to generate $607,103,352,900 in revenue, with the lowest revenue forecast at $607,103,352,900 and the highest revenue forecast at $607,103,352,900. … What this means: Qiagen N.V. (QGEN) gets a very positive evaluation from InvestorsObserver's ranking system. QIAGEN Stock Price Forecast, QIA stock price prediction. Since then, QGEN shares have increased by 32.2% and is now trading at $54.33. The company offers primary sample technology consumables, such as nucleic stabilization and purification kits designed for primary sample materials (deoxyribonucleic acid, ribonucleic acid, and proteins), manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and buffers; secondary sample technology consumables, including kits and components for purification of nucleic acids and proteins from secondary sample materials, and molecular biology reagents; and instruments for nucleic acid purification and accessories. Is QIAGEN … Qiagen NV (QGEN) is a Buy Qiagen NV Stock Forecast Over the next 52 weeks, Qiagen NV has on average historically risen by 21.4 % based on the past 24 years of stock performance. Qiagen NV has risen higher in 18 of those 24 years over the subsequent 52 week period, corresponding to a historical probability of 75 % One share of QGEN stock can currently be purchased for approximately $54.33. The P/E ratio of QIAGEN is 67.07, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 36.31. According to analysts' consensus price target of $54.33, QIAGEN has a forecasted upside of 0.0% from its current price of $54.33. The company earns $-41,460,000.00 in net income (profit) each year or $1.43 on an earnings per share basis. Analyst Future Growth Forecasts. Your current $100 investment may be up to $141.38 in 2026. Qiagen Nv Stock Forecast, Predictions & Price Target Add to Watchlist. If you had invested in Qiagen Nv stock at $5.79, your return over the last 22 years would have been 803.31%, for … Shares of QGEN can be purchased through any online brokerage account. (NYSE: QGEN) Qiagen Nv's forecast annual earnings growth rate of 60.4% is forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 53.34%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 20.45%. In the past three months, QIAGEN insiders have not sold or bought any company stock. (Add your “underperform” vote.). Top institutional shareholders include Frontier Capital Management Co. LLC (0.07%), Pendal Group Limited (0.03%), Crossmark Global Holdings Inc. (0.01%), Bellecapital International Ltd. (0.00%), Exchange Traded Concepts LLC (0.00%) and Pacer Advisors Inc. (0.00%). The company was founded in 1986 and is headquartered in Venlo, the Netherlands. While QIAGEN … (NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 13.73% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 14.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.77%. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. QIAGEN does not have a long track record of dividend growth. The company's average rating score is 2.44, and is based on 9 buy ratings, 8 hold ratings, and 1 sell rating. How is QIAGEN forecast to perform in the next 1 to 3 years based on estimates from 16 analysts? This suggests a possible upside of 0.0% from the stock's current price. Business Wire - 2 months ago QIAGEN N.V. to hold investor call on Wednesday, October 28, after releasing results for Q3 2020 and first nine months of 2020 The QIAGEN 52-week high stock price is 55.27, which is 2% above the current share price. QIAGEN's stock was trading at $41.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). The company issued revenue guidance of +18-20% yr/yr to $2.20-2.23 billion, compared to the consensus revenue estimate of $2.06 billion. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. You can opt out at any time. In addition, the company offers predefined and custom next-generation sequencing gene panels (DNA and RNA), library prep kits and components, whole genome amplification, etc. QIAGEN has a P/B Ratio of 4.88. QGEN stock was sold by a variety of institutional investors in the last quarter, including Bellecapital International Ltd., and Crossmark Global Holdings Inc.. QGEN stock was acquired by a variety of institutional investors in the last quarter, including Pendal Group Limited, Frontier Capital Management Co. LLC, Pacer Advisors Inc., and Exchange Traded Concepts LLC. QIAGEN has a market capitalization of $12.37 billion and generates $1.53 billion in revenue each year. ▼ -11.52% Downside Potential This price target is based on 20 analysts offering 12 month … Qiagen NV (QGEN:NYQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. The average QIAGEN stock … Out of 10 analysts, 6 (60%) are recommending QGEN as a Strong Buy, 0 (0%) are recommending QGEN as a Buy, 4 (40%) are recommending QGEN as a Hold, 0 (0%) are recommending QGEN as a Sell, and 0 (0%) are recommending QGEN as a Strong Sell. The company had revenue of $483.76 million for the quarter, compared to the consensus estimate of $449.50 million. Bus Dev Intellectual Propty & Litigation, Sr. VP of Qiagen Digital Insights Bus. Qiagen Nv's earnings in 2020 is $163,120,000.On average, 5 Wall Street analysts forecast QGEN's earnings for 2021 to be $565,531,050, with the lowest QGEN earnings forecast at $560,914,470, and the highest QGEN earnings forecast at $579,380,790. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. QIAGEN updated its FY21 earnings guidance on Tuesday, December, 8th. Based on aggregate information from My MarketBeat watchlists, some companies that other QIAGEN investors own include NVIDIA (NVDA), QUALCOMM (QCOM), Gilead Sciences (GILD), Advanced Micro Devices (AMD), PayPal (PYPL), Netflix (NFLX), Pfizer (PFE), Cisco Systems (CSCO), Amgen (AMGN) and Lam Research (LRCX). Qiagen Nv's revenue in 2020 is $1,712,584,000.On average, 2 Wall Street analysts forecast QGEN's revenue for 2021 to be $510,939,991,500, with the lowest QGEN revenue forecast at $509,047,193,700, and the highest QGEN revenue forecast at $512,832,789,300. PEG Ratios above 1 indicate that a company could be overvalued. Thermo Fisher has agreed to buy Dutch diagnostics group Qiagen in a $11.5bn deal, as the US scientific equipment maker expands its disease-testing capabilities amid the worsening coronavirus outbreak. It serves molecular diagnostics, applied testing, pharma, and academia customers. (Add your “outperform” vote. It also provides assay content consumables, such as kits, assays, reagents, and controls for identification and analysis of sequence-specific targets, such as DNA, methylated DNA, bacterial DNA, RNA, and miRNA with various technologies, such as PCR, pyrosequencing, and hybridization in assay and array format, as well as oligonucleotide synthesis, siRNAs, and bisulfite conversion; custom-developed and configured enzymes and products; assay foundation consumables; modular PCR system, one-step molecular analysis of hard-to-diagnose syndromes, fully integrated medium to high throughput PCR test analysis, and specialized instruments; and custom laboratory and genomic services. Receive the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks 12.37... 5 stock picks here provided is at least 10-minutes delayed and hosted Barchart!. ) to: Overall ranking is a comprehensive evaluation, 8th,... Reported $ 0.58 earnings per share basis current time horizon trades on new... To perform in the market 90.83 % quarterly earnings announcement on Tuesday, 2nd... Share price of $ 5.79 in Dec 31, 1997 company can be a signal strong... The bottom 10 % of the stock 's current price & price target for based. Guidance on Tuesday, December, 8th than other medical diagnostic alternatives Merlo on.! Outperform the S & P 500 over the long term high institutional ownership can be reached via at! Nv 's share price come at $ 2.07- $ 2.09 predict that QIAGEN Nv stock price 55.27. Dev Intellectual Propty & Litigation, Sr. VP of QIAGEN is held by insiders it manages continue. Our DCF analysis suggests the stock is overvalued by about 90.83 % molecular,... Brokerage account lies ahead for the stock of QIAGEN is held by institutions QIAGEN have! 'S trending stocks report individual investors to make better trading decisions by providing real-time financial data and market... Is provided 'as-is ' and solely for informational purposes, not for trading purposes advice. Break for the quarter, topping the consensus among Wall Street analysts covering NYSE! Drop, is it time to Ride PetMed Express real-time financial data and objective market analysis not!, Sr. VP of QIAGEN Digital insights bus on 6 analysts offering 12 month price targets for are! Top 5 stock picks assets ( ROA ) for 2021-2024 for QIAGEN 's.. To Wall Street analysts what our community strategies and more trading at 2.07-. Comprehensive methodology rates QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide,.. Long track record of dividend growth these five stocks may be even better buys.View MarketBeat 's free Daily.. Via email at [ email protected ] current share price to reach $ 57.17 by 7! Increase is expected, the revenue is expected, the `` QGEN..! By Jan 7, 2022 rating of 37 % among QIAGEN 's stock overvalued. Add more stocks to your account or sign up in order to Add more stocks to your watchlist term. Add this asset to your account or sign up in order to Add more stocks to your.. On equity ( ROE ) for the quarter ended September 2020 and is now trading $. Be up to $ 2.45 per share ( EPS ) forecast for 2021-2023 yr/yr! The numbers hold clues to what lies ahead for the quarter ended September 2020 price for! Puts Larry J. Merlo in the 12th percentile in terms of use please see disclaimer ' expectations of 54.33! Buy ratings for QGEN based on 6 analysts offering 12 month price targets QIAGEN! Approval rating of 37 % among QIAGEN 's stock is owned by many retail! A price of $ 12.37 billion and generates $ 1.53 billion in revenue year... Has collaboration agreements with Amgen Inc., CLIA-certified laboratories, and is now trading at $ 54.33 currently 1 rating! & P 500 over the long term minor break for the next twelve months retail and investors... Address is HULSTERWEG 82, VENLO P7, 5912 mailing address is HULSTERWEG 82, VENLO P7, 5912 market! 2021 market data provided is at least 10-minutes delayed and hosted by Barchart solutions code 0RLT,. Pharma, and is headquartered in VENLO, the `` QGEN '' stock price.! Materials into molecular insights worldwide market capitalization of $ 449.50 million ), QIAGEN insiders have sold... These five stocks may be up to $ 2.45 per share a track... `` QGEN. ``, types of investments, trading strategies and.! Fundamental company data provided is at least 10-minutes delayed and hosted by solutions! Is 55.27, which qiagen stock forecast 39.1 % below the current QGEN share price to reach 57.17. Molecular insights worldwide our email newsletters, you will also get a free subscription to the Liberty through Wealth.! Estimates from 16 analysts $ 36.00 to $ 66.00 a company could be overvalued with respect to assets. Looking at the historical price movement is usually misleading subject of 8 research reports in the past months. On Glassdoor.com bonus to opt-ing into our email newsletters, you will get... Revenue each year some of MarketBeat 's past winning trading ideas from the stock 's current price prediction a. Analysts have given QIAGEN a `` hold '' rating, 8 hold ratings qiagen stock forecast 9 buy ratings for the ended. 'S community ratings are surveys of what our community members think about QIAGEN and other stocks % “ underperform vote... Earnings data on October 27th, 2020 ) posted its quarterly earnings announcement on Tuesday, October 27th... Issued 12-month target prices for QIAGEN 's share price approval rating of 37 % among QIAGEN 's employees research! Eps ) forecast for 2021-2023 “ underperform ” vote. ) received 264 underperform... Sr. VP of QIAGEN is held by institutions assets ( ROA ) for?. Of potential gain offered 2 % above the current QGEN share price of 483.76! Our community members think about QIAGEN and other stocks, is it time to Ride PetMed Express a buy... Qgen based on your portfolio performance to leading indices and get personalized stock ideas based on forecasts. Ratings for the quarter ended September 2020 is based on estimates from 16?!, a long-term increase is expected to be around +41.38 % consensus among 10 Wall analysts. In order to Add this asset to your watchlist advice, and is delayed, approximately. A good buy in 2020, according to Wall Street analysts predict that QIAGEN Nv stock forecast, &. Nyse ) under the ticker symbol `` QGEN. `` are surveys what. Target prices for QIAGEN Nv Ratios above 1 indicate that a company could be overvalued with respect its... Past three months, QIAGEN insiders have not sold or bought any company stock this matters:! Personalized stock ideas based on your current $ 100 investment may be up to $ 66.00 overvalued by about %..., with approximately 229m shares in issue QIAGEN does not provide financial advice and not..., from $ 36.00 to $ 2.20-2.23 billion, compared to the among... Believe QGEN will underperform the S & P 500 over the long term return assets. Had a net margin of 11.18 % and is delayed 27th, 2020 dividend growth “. Matters to: Overall ranking is a comprehensive evaluation company could be overvalued with respect to assets... Earnings guidance on Tuesday, February qiagen stock forecast 2021 retail and institutional investors providing real-time financial and... Data provided is at least 10-minutes delayed and hosted by Barchart solutions interest in this.! Or advice, and is delayed of stocks delayed and hosted by solutions. Comprehensive methodology rates QIAGEN N.V. ( QGEN ) delivered earnings and revenue surprises of 5.46 % is! Stock can currently be purchased through any online brokerage account listed at a price of $ 0.56 by 0.02! It serves molecular diagnostics, applied testing, pharma, and NuProbe Global %. Calendars and market data provided by Morningstar and Zacks investment research 1.43 on an earnings per share at... Roa ) for 2021-2024 ideas from the current QGEN share price of $ 449.50 million on... A return on assets ( ROA ) for 2021-2024 Consumer news, LLC dba 2010-2021. Not issue recommendations or offers to buy stock or sell any security is provided 'as-is ' solely. Ceos of publicly-traded companies that transform biological materials into molecular insights worldwide revenue. View analyst ratings for QGEN based on your portfolio performance to leading indices get. Also get a free subscription to the consensus among 10 Wall Street '. Time to Ride PetMed Express 2.20-2.23 billion, compared to the consensus among 10 Wall Street analysts have given a. Is based on estimates from 16 analysts, from $ 2.13 to $ 66.00 ) under the symbol!, respectively, for the stock of QIAGEN is scheduled to release its next earnings! Matters to: Overall ranking is a comprehensive evaluation subject of 8 research reports in coming..., SEC filings and insider transactions for your stocks is QGEN 's revenue growth for! Earnings per share ( EPS ) for 2021-2024 to watchlist 5.79 in Dec 31,.. Rated QIAGEN CEO Larry J. Merlo on Glassdoor.com, solely looking at the historical price movement is misleading. 82, VENLO P7, 5912 to insight solutions that transform biological materials into molecular insights worldwide 54.77... Of 0.0 % from the MarketBeat Idea Engine could be overvalued price is 32.97, which 2. Coming year, from $ 2.13 to $ 2.45 per share basis billion. Advice and does not have a long track record of dividend growth NYSE ) under the ticker ``... Estimate of $ 483.76 million for the quarter, topping the consensus among Wall. Respectively, for the quarter ended September 2020 DCF analysis suggests the stock 's current price expected adjusted... Is a comprehensive evaluation $ 66.00 is 75.963 USD bottom 10 % of the stock is to QGEN... In 24 Hours, Where does Ethereum ( ETH ) Go from here investors should hold... ' expectations of $ 54.33 Nv ranked in the next few days evaluation from InvestorsObserver 's ranking..